Manulife (Manufacturers Life Insurance)’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-932
| Closed | -$26.1K | – | 2976 |
|
|
2023
Q4 | $26.1K | Sell |
932
-1,065
| -53% | -$29.8K | ﹤0.01% | 2930 |
|
|
2023
Q3 | $95K | Hold |
1,997
| – | – | ﹤0.01% | 2827 |
|
|
2023
Q2 | $191K | Buy |
1,997
+566
| +40% | +$54.2K | ﹤0.01% | 2628 |
|
|
2023
Q1 | $162K | Hold |
1,431
| – | – | ﹤0.01% | 2633 |
|
|
2022
Q4 | $160K | Sell |
1,431
-135
| -9% | -$15.1K | ﹤0.01% | 2656 |
|
|
2022
Q3 | $201K | Sell |
1,566
-59
| -4% | -$7.57K | ﹤0.01% | 2587 |
|
|
2022
Q2 | $111K | Buy |
1,625
+126
| +8% | +$8.64K | ﹤0.01% | 2871 |
|
|
2022
Q1 | $213K | Sell |
1,499
-352
| -19% | -$50.1K | ﹤0.01% | 2731 |
|
|
2021
Q4 | $308 | Sell |
1,851
-48
| -3% | -$8 | ﹤0.01% | 2590 |
|
|
2021
Q3 | $264K | Sell |
1,899
-74
| -4% | -$10.3K | ﹤0.01% | 2773 |
|
|
2021
Q2 | $941K | Buy |
1,973
+399
| +25% | +$190K | ﹤0.01% | 2029 |
|
|
2021
Q1 | $648K | Sell |
1,574
-90
| -5% | -$37.1K | ﹤0.01% | 2132 |
|
|
2020
Q4 | $815K | Buy |
1,664
+133
| +9% | +$65.1K | ﹤0.01% | 1939 |
|
|
2020
Q3 | $867K | Buy |
1,531
+123
| +9% | +$69.7K | ﹤0.01% | 1727 |
|
|
2020
Q2 | $131K | Buy |
1,408
+62
| +5% | +$5.77K | ﹤0.01% | 2660 |
|
|
2020
Q1 | $96K | Buy |
1,346
+90
| +7% | +$6.42K | ﹤0.01% | 2589 |
|
|
2019
Q4 | $87K | Buy |
1,256
+60
| +5% | +$4.16K | ﹤0.01% | 2817 |
|
|
2019
Q3 | $94K | Buy |
+1,196
| New | +$94K | ﹤0.01% | 2836 |
|
|
2018
Q3 | – | Sell |
-997
| Closed | -$171K | – | 3498 |
|
|
2018
Q2 | $171K | Buy |
997
+105
| +12% | +$18K | ﹤0.01% | 3236 |
|
|
2018
Q1 | $130K | Buy |
892
+8
| +0.9% | +$1.17K | ﹤0.01% | 3320 |
|
|
2017
Q4 | $178K | Buy |
884
+32
| +4% | +$6.44K | ﹤0.01% | 3094 |
|
|
2017
Q3 | $273K | Sell |
852
-62
| -7% | -$19.9K | ﹤0.01% | 2731 |
|
|
2017
Q2 | $206K | Buy |
914
+121
| +15% | +$27.3K | ﹤0.01% | 2987 |
|
|
2017
Q1 | $178K | Buy |
793
+82
| +12% | +$18.4K | ﹤0.01% | 2908 |
|
|
2016
Q4 | $140K | Buy |
711
+15
| +2% | +$2.95K | ﹤0.01% | 3046 |
|
|
2016
Q3 | $171K | Buy |
696
+41
| +6% | +$10.1K | ﹤0.01% | 2884 |
|
|
2016
Q2 | $381K | Buy |
655
+335
| +105% | +$195K | ﹤0.01% | 2211 |
|
|
2016
Q1 | $161K | Buy |
320
+236
| +281% | +$119K | ﹤0.01% | 2752 |
|
|
2015
Q4 | $59 | Buy |
84
+75
| +833% | +$53 | ﹤0.01% | 3243 |
|
|
2015
Q3 | $5 | Buy |
+9
| New | +$5 | ﹤0.01% | 3685 |
|